199 related articles for article (PubMed ID: 31669219)
1. Benzimidazole-based dual dipeptidyl peptidase-4 and xanthine oxidase inhibitors.
Tomovic K; Ilic BS; Smelcerovic Z; Miljkovic M; Yancheva D; Kojic M; Mavrova AT; Kocic G; Smelcerovic A
Chem Biol Interact; 2020 Jan; 315():108873. PubMed ID: 31669219
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of xanthine derivatives on dipeptidyl peptidase 4.
Lin K; Cai Z; Wang F; Zhang W; Zhou W
Chem Pharm Bull (Tokyo); 2013; 61(4):477-82. PubMed ID: 23358258
[TBL] [Abstract][Full Text] [Related]
3. Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation.
Meduru H; Wang YT; Tsai JJ; Chen YC
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304951
[TBL] [Abstract][Full Text] [Related]
4. Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
Li N; Wang LJ; Jiang B; Li XQ; Guo CL; Guo SJ; Shi DY
Eur J Med Chem; 2018 May; 151():145-157. PubMed ID: 29609120
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
Patel BD; Bhadada SV; Ghate MD
Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel xanthine compounds targeting DPP-IV and GPR119 as anti-diabetic agents.
Li G; Huan Y; Yuan B; Wang J; Jiang Q; Lin Z; Shen Z; Huang H
Eur J Med Chem; 2016 Nov; 124():103-116. PubMed ID: 27560285
[TBL] [Abstract][Full Text] [Related]
7. Integrated Protocol to Design Potential Inhibitors of Dipeptidyl Peptidase- 4 (DPP-4).
Pantaleão SQ; Philot EA; de Oliveira Almeida M; Lima AN; de Sairre MI; Scott AL; Honorio KM
Curr Top Med Chem; 2020; 20(3):209-226. PubMed ID: 31878857
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of dipeptidyl peptidase IV and xanthine oxidase by amino acids and dipeptides.
Nongonierma AB; Mooney C; Shields DC; Fitzgerald RJ
Food Chem; 2013 Nov; 141(1):644-53. PubMed ID: 23768405
[TBL] [Abstract][Full Text] [Related]
9. Benzo[4,5]thieno[2,3-d]pyrimidine phthalimide derivative, one of the rare noncompetitive inhibitors of dipeptidyl peptidase-4.
Tomovic K; Ilic BS; Miljkovic M; Dimov S; Yancheva D; Kojic M; Mavrova AT; Kocic G; Smelcerovic A
Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900238. PubMed ID: 31710123
[TBL] [Abstract][Full Text] [Related]
10. Rapid generation of novel benzoic acid-based xanthine derivatives as highly potent, selective and long acting DPP-4 inhibitors: Scaffold-hopping and prodrug study.
Li Q; Meng L; Zhou S; Deng X; Wang N; Ji Y; Peng Y; Xing J; Yao G
Eur J Med Chem; 2019 Oct; 180():509-523. PubMed ID: 31336309
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel pyrimidinedione derivatives as DPP-4 inhibitors.
Li N; Wang LJ; Jiang B; Guo SJ; Li XQ; Chen XC; Luo J; Li C; Wang Y; Shi DY
Bioorg Med Chem Lett; 2018 Jul; 28(12):2131-2135. PubMed ID: 29773502
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, biological evaluation, and docking studies of (s)-phenylalanine derivatives with a 2-cyanopyrrolidine moiety as potent dipeptidyl peptidase 4 inhibitors.
Liu Y; Wu Y; Wu H; Tang L; Wu P; Liu T; Hu Y
Chem Biol Drug Des; 2013 Aug; 82(2):140-6. PubMed ID: 23530834
[TBL] [Abstract][Full Text] [Related]
13. Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554.
Maezaki H; Banno Y; Miyamoto Y; Moritoh Y; Asakawa T; Kataoka O; Takeuchi K; Suzuki N; Ikedo K; Kosaka T; Sasaki M; Tsubotani S; Tani A; Funami M; Yamamoto Y; Tawada M; Aertgeerts K; Yano J; Oi S
Bioorg Med Chem; 2011 Aug; 19(15):4482-98. PubMed ID: 21741847
[TBL] [Abstract][Full Text] [Related]
14. Identification of Potential Dipeptidyl Peptidase (DPP)-IV Inhibitors among
Yang Y; Shi CY; Xie J; Dai JH; He SL; Tian Y
Molecules; 2020 Jan; 25(1):. PubMed ID: 31906524
[No Abstract] [Full Text] [Related]
15. Design, Synthesis and Biological Evaluation of Imidazo[1,2-a]pyridine Derivatives as Novel DPP-4 Inhibitors.
Li Q; Zhou M; Han L; Cao Q; Wang X; Zhao L; Zhou J; Zhang H
Chem Biol Drug Des; 2015 Oct; 86(4):849-56. PubMed ID: 25787859
[TBL] [Abstract][Full Text] [Related]
16. Discovery of anthraquinones as DPP-IV inhibitors: Structure-activity relationships and inhibitory mechanism.
Ma HH; Zhang J; Li CQ; Zou LW
Fitoterapia; 2023 Jul; 168():105549. PubMed ID: 37244503
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel benzyl-substituted (S)-phenylalanine derivatives as potent dipeptidyl peptidase 4 inhibitors.
Liu Y; Si M; Tang L; Shangguan S; Wu H; Li J; Wu P; Ma X; Liu T; Hu Y
Bioorg Med Chem; 2013 Sep; 21(18):5679-87. PubMed ID: 23938053
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
Musoev A; Numonov S; You Z; Gao H
Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
[TBL] [Abstract][Full Text] [Related]
19. Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor, decreases serum uric acid levels in type 2 diabetic patients partly by suppressing xanthine oxidase activity.
Yamagishi S; Ishibashi Y; Ojima A; Sugiura T; Matsui T
Int J Cardiol; 2014 Sep; 176(2):550-2. PubMed ID: 25065332
[No Abstract] [Full Text] [Related]
20. Structure-based virtual screening of dipeptidyl peptidase 4 inhibitors and their in vitro analysis.
Rahman SU; Ali HS; Jafari B; Zaib S; Hameed A; Al-Kahraman YMSA; Langer P; Iqbal J
Comput Biol Chem; 2021 Apr; 91():107326. PubMed ID: 32739275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
